当前位置: X-MOL 学术Curr. Cardiol. Rep. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Complications Following MitraClip Implantation
Current Cardiology Reports ( IF 3.7 ) Pub Date : 2021-08-13 , DOI: 10.1007/s11886-021-01553-9
Katharina Schnitzler 1 , Michaela Hell 1 , Martin Geyer 1 , Felix Kreidel 1 , Thomas Münzel 1 , Ralph Stephan von Bardeleben 1
Affiliation  

Purpose of Review

To provide a detailed overview of complications associated with MitraClip therapy and its development over time with the aim to alert physicians for early recognition of complications and to offer treatment strategies for each complication, if possible.

Recent Findings

The MitraClip system (MC) is the leading transcatheter technique to treat mitral regurgitation (MR) and has been established as a safe procedure with very low adverse event rates compared to mitral surgery at intermediate to high risk or in secondary MR. Lately, the fourth MC generation has been launched with novel technical features to facilitate device handling, decrease complication rates, and allow the treatment of even complex lesions.

Summary

Although the complication rate is low, adverse events are associated with increased morbidity and mortality. The most common complications are bleeding, acute kidney failure, procedure-induced mitral stenosis, and an iatrogenic atrial septal defect with unknown clinical impact.



中文翻译:

MitraClip 植入后的并发症

审查目的

提供与 MitraClip 治疗相关的并发症及其随时间发展的详细概述,目的是提醒医生及早识别并发症,并在可能的情况下为每种并发症提供治疗策略。

最近的发现

MitraClip 系统 (MC) 是治疗二尖瓣关闭不全 (MR) 的领先经导管技术,与中高风险或继发性 MR 的二尖瓣手术相比,它已被确立为一种安全的手术,不良事件发生率非常低。最近,第四代 MC 推出,具有新的技术特点,以方便设备处理、降低并发症发生率,并允许治疗甚至复杂的病变。

概括

尽管并发症发生率很低,但不良事件与发病率和死亡率增加有关。最常见的并发症是出血、急性肾功能衰竭、手术引起的二尖瓣狭窄和临床影响未知的医源性房间隔缺损。

更新日期:2021-08-19
down
wechat
bug